343 related articles for article (PubMed ID: 33713810)
21. Surgical macular decompression for macular edema in retinal vein occlusion.
Mandelcorn MS; Mandelcorn E; Guan K; Adatia FA
Can J Ophthalmol; 2007 Feb; 42(1):116-22. PubMed ID: 17361252
[TBL] [Abstract][Full Text] [Related]
22. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
23. [Whole course management is the key to retinal vein occlusion].
Zhao MW; Miao H
Zhonghua Yan Ke Za Zhi; 2020 Apr; 56(4):246-249. PubMed ID: 32306615
[TBL] [Abstract][Full Text] [Related]
24. Interventions for central retinal vein occlusion: an evidence-based systematic review.
Mohamed Q; McIntosh RL; Saw SM; Wong TY
Ophthalmology; 2007 Mar; 114(3):507-19, 524. PubMed ID: 17324695
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.
Feng XX; Li C; Shao WW; Yuan YG; Qian XB; Zheng QS; Li YJ; Gao QY
Int J Ophthalmol; 2018; 11(3):429-437. PubMed ID: 29600177
[TBL] [Abstract][Full Text] [Related]
26. EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.
Sun Z; Zhou H; Lin B; Jiao X; Luo Y; Zhang F; Tao S; Wu Q; Ke Z; Liu X
Retina; 2017 Sep; 37(9):1723-1730. PubMed ID: 27893623
[TBL] [Abstract][Full Text] [Related]
27. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Mitry D; Bunce C; Charteris D
Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
[TBL] [Abstract][Full Text] [Related]
28. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
29. Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion.
Ogino K; Tsujikawa A; Murakami T; Muraoka Y; Kurashige Y; Yoshimura N
Clin Ophthalmol; 2011; 5():1031-6. PubMed ID: 21845030
[TBL] [Abstract][Full Text] [Related]
30. Anti-VEGF Therapy and Retinal Photocoagulation to Prevent Recurrence of Central Retinal Vein Occlusion: Two Case Reports of Young Patients.
Suzuki T; Matsumoto F; Sakamoto S; Nakagawa Y; Suzuki Y
Tokai J Exp Clin Med; 2020 Dec; 45(4):249-253. PubMed ID: 33300598
[TBL] [Abstract][Full Text] [Related]
31. Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study.
Feltgen N; Hattenbach LO; Bertelmann T; Callizo J; Rehak M; Wolf A; Berk H; Eter N; Lang GE; Pielen A; Schmitz-Valckenberg S; Quiering C; Rose U; Hoerauf H;
Acta Ophthalmol; 2018 Dec; 96(8):e933-e941. PubMed ID: 29855153
[TBL] [Abstract][Full Text] [Related]
32. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.
Callizo J; Atili A; Striebe NA; Bemme S; Feltgen N; Hoerauf H; Bertelmann T
Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):913-920. PubMed ID: 30610424
[TBL] [Abstract][Full Text] [Related]
33. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
Zhang W; Liu Y; Sang A
BMC Ophthalmol; 2022 Dec; 22(1):472. PubMed ID: 36474156
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Gewaily D; Greenberg PB
Cochrane Database Syst Rev; 2009 Jan; (1):CD007324. PubMed ID: 19160332
[TBL] [Abstract][Full Text] [Related]
36. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
Hu Q; Li H; Xu W; Du Y; Ma C; He J
Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
38. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
[TBL] [Abstract][Full Text] [Related]
39. [Management of macular edema secondary to retinal vein occlusion].
Girmens JF; Glacet-Bernard A; Kodjikian L; Nghiêm-Buffet S; Massé H; Fourmaux E; Wolff B; Roquet W; Gaucher D; Baillif S; Tadayoni R
J Fr Ophtalmol; 2015 Mar; 38(3):253-63. PubMed ID: 25683131
[TBL] [Abstract][Full Text] [Related]
40. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial.
Song S; Yu X; Zhang P; Gu X; Dai H
BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
